Mustafa Korkmaz

10PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Nutrigenomics and personalised nutritionHaematological tumoursObstetrics and gynaecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 26, 2026
Early PSA Decline Predicts Survival Outcomes in Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Retrospective Single-Center Study.

|Feb 27, 2026
Prognostic Significance of Albumin-Bilirubin (ALBI) Score in Gastric Cancer Patients Undergoing Curative Resection Followed by Adjuvant Therapy.

Talat Aykut, Oğuzhan Yıldız, Bahattin Engin Kaya

|Aug 28, 2024
Comparison of granisetron and palonosetron in triplet anti-emetic prophylaxis in non-small cell lung cancer patients receiving cisplatin-based highly emetogenic chemotherapy.

Murat Araz, Ismail Beypinar, Fatih Inci

|Mar 13, 2024
The effect of concomitant beta-blocker use on survival in patients with metastatic renal cell carcinoma treated with a vascular endothelial growth factor receptor inhibitors in the first line.

Mustafa Korkmaz, Melek Karakurt Eryılmaz, Mehmet Zahid Koçak

|Sep 22, 2023
Is the Prognostic Nutritional Index a Prognostic Marker for the Survival of Patients with Lymph-Node Positive Stage II-III Gastric Cancer Who Receive Adjuvant Chemotherapy?

Mustafa Korkmaz, Melek Karakurt Eryılmaz, Muhammed Muhiddin Er

|Apr 11, 2022
Prognostic Significance of Adipose Tissue Distribution and Metabolic Activity in PET/CT in Patients with Metastatic Colorectal Cancer.

Tuba Karaçelik, Buğra Kaya, Mustafa Korkmaz

Pageof 2

Frequent Collaborators

10 joint publications

Mehmet Artaç

8 joint publications

Melek Karakurt Eryılmaz

6 joint publications

Mustafa Karaağaç

6 joint publications

Murat Araz